Sundaram Preethi sold CPRX
December 8, 2025 · Form 4 insider transaction
Sundaram Preethi sold 1,669 shares of Catalyst Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,669
Price
N/A
Total value
N/A
InsiderSundaram Preethi
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after50,506
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.